260 related articles for article (PubMed ID: 24962661)
21. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patients.
Tae BS; Kim JK; Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Sci Rep; 2017 May; 7(1):1380. PubMed ID: 28469275
[TBL] [Abstract][Full Text] [Related]
24. Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy.
Ajili F; Manai M; Darouiche A; Chebil M; Boubaker S
Ultrastruct Pathol; 2012 Oct; 36(5):320-4. PubMed ID: 23025650
[TBL] [Abstract][Full Text] [Related]
25. The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking.
Ogihara K; Kikuchi E; Yuge K; Yanai Y; Matsumoto K; Miyajima A; Asakura H; Oya M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1039-1047. PubMed ID: 27660257
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of P-cadherin in non-muscle-invasive bladder cancer.
Wang P; Lin SL; Zhang LH; Li Z; Liu Q; Gao JX; Liu DM; Bo JJ; Huang YR
Eur J Surg Oncol; 2014 Mar; 40(3):255-9. PubMed ID: 24429027
[TBL] [Abstract][Full Text] [Related]
27. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
28. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
29. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
[TBL] [Abstract][Full Text] [Related]
30. Areca Nut Chewing and an Impaired Estimated Glomerular Filtration Rate as Significant Risk Factors for Non-Muscle-Invasive Bladder Cancer Recurrence.
Cao J; Xu R; Zhao X; Zhong Z; Zhang L; Zhu X; Wu S; Ai K
Sci Rep; 2016 Jul; 6():29466. PubMed ID: 27385379
[TBL] [Abstract][Full Text] [Related]
31. Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
Lodde M; Mian C; Mayr R; Comploj E; Trenti E; Melotti R; Campodonico F; Maffezzini M; Fritsche HM; Pycha A
Int J Urol; 2014 Oct; 21(10):968-72. PubMed ID: 24947145
[TBL] [Abstract][Full Text] [Related]
32. Short-term change in kidney function and risk of end-stage renal disease.
Turin TC; Coresh J; Tonelli M; Stevens PE; de Jong PE; Farmer CK; Matsushita K; Hemmelgarn BR
Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
[TBL] [Abstract][Full Text] [Related]
33. Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
Kwak C; Ku JH; Park JY; Lee E; Lee SE; Lee C
J Urol; 2004 Jan; 171(1):149-52. PubMed ID: 14665864
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of inflammation or granuloma after intravesival BCG in non-muscle-invasive bladder cancer.
Jallad S; Goubet S; Symes A; Larner T; Thomas P
BJU Int; 2014 May; 113(5b):E22-7. PubMed ID: 24717097
[TBL] [Abstract][Full Text] [Related]
35. Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer.
Gou Y; Ding W; Xu K; Wang H; Chen Z; Tan J; Xia G; Ding Q
Int Urol Nephrol; 2015 Feb; 47(2):289-93. PubMed ID: 25388353
[TBL] [Abstract][Full Text] [Related]
36. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH
Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724
[TBL] [Abstract][Full Text] [Related]
37. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer.
Grotenhuis AJ; Ebben CW; Aben KK; Witjes JA; Vrieling A; Vermeulen SH; Kiemeney LA
Urol Oncol; 2015 Feb; 33(2):65.e9-17. PubMed ID: 25023787
[TBL] [Abstract][Full Text] [Related]
38. Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer.
Matsumoto K; Kikuchi E; Shirakawa H; Hayakawa N; Tanaka N; Ninomiya A; Miyajima A; Nakamura S; Oya M
BJU Int; 2012 Dec; 110(11 Pt B):E508-13. PubMed ID: 22574662
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer.
Gazzaniga P; de Berardinis E; Raimondi C; Gradilone A; Busetto GM; De Falco E; Nicolazzo C; Giovannone R; Gentile V; Cortesi E; Pantel K
Int J Cancer; 2014 Oct; 135(8):1978-82. PubMed ID: 24599551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
